Dorry Boll

646 total citations
25 papers, 285 citations indexed

About

Dorry Boll is a scholar working on Oncology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Dorry Boll has authored 25 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Obstetrics and Gynecology and 5 papers in Surgery. Recurrent topics in Dorry Boll's work include Cancer survivorship and care (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Dorry Boll is often cited by papers focused on Cancer survivorship and care (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Dorry Boll collaborates with scholars based in Netherlands, United States and Indonesia. Dorry Boll's co-authors include Lonneke V. van de Poll‐Franse, Johanna M.A. Pijnenborg, M. Caroline Vos, Floortje Mols, Nicole P. M. Ezendam, Nicole P. M. Ezendam, Belle H. de Rooij, Paul J. J. M. Klinkhamer, Mies van Eenbergen and Joanne A. de Hullu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Dorry Boll

22 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dorry Boll Netherlands	12	134	61	46	42	41	25	285
Mary Kathryn Abel United States	9	90 0.7×	33 0.5×	17 0.4×	50 1.2×	53 1.3×	50	269
Suzana Sales de Aguiar Brazil	15	369 2.8×	74 1.2×	16 0.3×	25 0.6×	95 2.3×	36	567
Catherine Bender United States	10	162 1.2×	40 0.7×	10 0.2×	53 1.3×	17 0.4×	16	462
Hislop Tg Canada	10	209 1.6×	101 1.7×	24 0.5×	50 1.2×	65 1.6×	13	433
F. Ghaemmaghami Iran	10	186 1.4×	103 1.7×	7 0.2×	67 1.6×	71 1.7×	23	353
David Gómez Spain	11	137 1.0×	41 0.7×	21 0.5×	6 0.1×	26 0.6×	25	278
Meghan R. Flanagan United States	12	132 1.0×	12 0.2×	32 0.7×	36 0.9×	142 3.5×	33	447
Richard Lee United States	8	328 2.4×	76 1.2×	5 0.1×	22 0.5×	36 0.9×	11	453
Sandra Kereakoglow United States	8	334 2.5×	16 0.3×	10 0.2×	14 0.3×	43 1.0×	11	505
Jason A. Lachance United States	13	104 0.8×	128 2.1×	20 0.4×	223 5.3×	117 2.9×	18	442

Countries citing papers authored by Dorry Boll

Since Specialization

Citations

This map shows the geographic impact of Dorry Boll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorry Boll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorry Boll more than expected).

Fields of papers citing papers by Dorry Boll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorry Boll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorry Boll. The network helps show where Dorry Boll may publish in the future.

Co-authorship network of co-authors of Dorry Boll

This figure shows the co-authorship network connecting the top 25 collaborators of Dorry Boll. A scholar is included among the top collaborators of Dorry Boll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorry Boll. Dorry Boll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wenzel, Hans H.B., et al.. (2025). Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approaches. Gynecologic Oncology. 203. 139–150.

Reijnen, Casper, Dorry Boll, Nicole C.M. Visser, et al.. (2025). Implementation of a Personalized Risk Model for Lymph Node Metastasis in Endometrial Carcinoma: Healthcare Providers' Perspectives on Use, Barriers, and Facilitators. Cancer Medicine. 14(15). e71103–e71103.

Ezendam, Nicole P. M., Belle H. de Rooij, Carien L. Creutzberg, et al.. (2024). Effect of reduced follow-up care on patient satisfaction with care among patients with endometrial cancer: The ENSURE randomized controlled trial. Gynecologic Oncology. 188. 169–183. 2 indexed citations

Eenbergen, Mies van, et al.. (2024). ‘There is still a part of me that would love to be the old me again’, how do adolescents and young adults (AYA) experience cancer-related bodily changes: a phenomenological interview study. Journal of Cancer Survivorship. 19(5). 1623–1633. 2 indexed citations

Linden, M. van der, Marc van Beurden, Johan Bulten, et al.. (2022). The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease. American Journal of Obstetrics and Gynecology. 227(2). 250.e1–250.e8. 17 indexed citations

Rooij, Belle H. de, M. Caroline Vos, Dorry Boll, et al.. (2021). Cancer-related psychosocial factors and self-reported changes in lifestyle among gynecological cancer survivors: cross-sectional analysis of PROFILES registry data. Supportive Care in Cancer. 30(2). 1199–1207. 12 indexed citations

Walree, Inez Charlotte van, Marije E. Hamaker, Lonneke V. van de Poll‐Franse, et al.. (2019). Older ovarian cancer survivors report lower long-term health-related quality of life than younger survivors: A study from the population-based profiles registry. Gynecologic Oncology. 153(2). 391–398. 11 indexed citations

Vos, M. Caroline, Dorry Boll, Dennis van Hamont, et al.. (2019). Polymorphisms in MMP-14 and MMP-2 genes and ovarian cancer survival. Cancer Biomarkers. 25(3). 233–241. 4 indexed citations

Meeuwis, K.A.P., E.B.L. van Dorst, Johan Bulten, et al.. (2019). P191 Paget trial: topical 5% imiquimod for vulvar paget disease, first results of clinical efficacy. A170.3–A171. 1 indexed citations

10.

Eenbergen, Mies van, Dorry Boll, Paul J.M. Kil, et al.. (2019). Changes in internet use and wishes of cancer survivors: A comparison between 2005 and 2017. Cancer. 126(2). 408–415. 39 indexed citations

11.

Thong, Melissa S. Y., Floortje Mols, Adrian A. Kaptein, et al.. (2018). Illness perceptions are associated with higher health care use in survivors of endometrial cancer—a study from the population-based PROFILES registry. Supportive Care in Cancer. 27(5). 1935–1944. 15 indexed citations

12.

Bonhof, Cynthia S., Floortje Mols, Martine De Vos, et al.. (2018). Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study. Gynecologic Oncology. 149(3). 455–463. 37 indexed citations

13.

Klinkhamer, Paul J. J. M., et al.. (2018). Surgical margins in squamous cell carcinoma, different for the vulva?. European Journal of Surgical Oncology. 44(10). 1555–1561. 20 indexed citations

14.

Linden, M. van der, K.A.P. Meeuwis, E.B.L. van Dorst, et al.. (2017). The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease. JMIR Research Protocols. 6(9). e178–e178. 16 indexed citations

15.

Pouwer, Anne-Floor W., F. Hinten, Jacobus van der Velden, et al.. (2017). Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study. Gynecologic Oncology. 146(3). 580–587. 11 indexed citations

16.

Boll, Dorry, et al.. (2016). Vulvar mucinous adenocarcinoma with neuroendocrine differentiation: A case report and review of the literature. Pathology - Research and Practice. 212(3). 234–237. 4 indexed citations

17.

Boll, Dorry, et al.. (2016). High Incidence of Erysipelas After Surgical Treatment for Vulvar Carcinoma.. International Journal of Gynecological Cancer. 26(3). 582–587. 4 indexed citations

18.

Vos, M. Caroline, Eva Hollemans, Nicole P. M. Ezendam, et al.. (2016). MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer. Journal of Ovarian Research. 9(1). 53–53. 33 indexed citations

19.

Ezendam, Nicole P. M., Kim A.H. Nicolaije, Dorry Boll, et al.. (2013). Health Care Use Among Endometrial Cancer Survivors. International Journal of Gynecological Cancer. 23(7). 1258–1265. 12 indexed citations

20.

Poll‐Franse, Lonneke V. van de, Kim A.H. Nicolaije, Nicole P. M. Ezendam, et al.. (2013). The impact of an automatically generated survivorship care plan on patient reported outcomes (ROGY Care): Results of a pragmatic cluster randomized controlled trial among endometrial cancer patients.. Journal of Clinical Oncology. 31(15_suppl). e16517–e16517. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact